SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-18-144969
Filing Date
2018-05-01
Accepted
2018-05-01 07:15:32
Documents
3
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d578089d10ka.htm 10-K/A 24026
2 EX-31.1 d578089dex311.htm EX-31.1 6871
3 EX-31.2 d578089dex312.htm EX-31.2 7339
  Complete submission text file 0001193125-18-144969.txt   39267
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37766 | Film No.: 18793178
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences